Reasons for discontinuation of tuberculosis treatment provided by BRAC

To supplement the government tuberculosic; control programme, BRAC has initiated a communitybased tuberculosis programme in 10 thanas under the Women's Health and Development Programme (WHDP) (presently known as Reproductive Health and Disease Control - RHDC) since June 1992. BRAC is deliver...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Mahmud, Shah Noor, Ali, Ahmed, Islam, Md. Nazrul, Karim, Fazlul
Format: Research report
Sprache:English
Veröffentlicht: BRAC Research and Evaluation Division (RED) 2019
Schlagworte:
Online Zugang:http://hdl.handle.net/10361/12909
id 10361-12909
record_format dspace
spelling 10361-129092019-11-11T21:01:38Z Reasons for discontinuation of tuberculosis treatment provided by BRAC Mahmud, Shah Noor Ali, Ahmed Islam, Md. Nazrul Karim, Fazlul Tuberculosis BRAC Women's Health and Development Programme (WHDP) Tuberculosis--Treatment Health, Nutrition, and Population Program (BRAC) To supplement the government tuberculosic; control programme, BRAC has initiated a communitybased tuberculosis programme in 10 thanas under the Women's Health and Development Programme (WHDP) (presently known as Reproductive Health and Disease Control - RHDC) since June 1992. BRAC is delivering services and following up the patients for all compliance. But, a recent study showed that the treatment completion rate achieved was up to 85% (1). Now the question arises: why the remaining 15% of the patients did not complete their treatment course? This study aimed to assess the reasons for discontinuation of treatment from BRAC's community-based TB control programme. The study was carried out in all10 WHDP thanas and dealt with the patients receiving only 12 months treatment regimen. The patients who enrolled and later discontinued treatment dwing June 1993 to May 1994 were selected for the study. Reasons for discontinuation of treatment were collected from progranune records, the patient or his/her relatives, Shastho Shebikas (SSs), Programme Organisers (POs), Area Managers (AMs) and Medical Officers (MOs) through indepth interviews during J\Ule and August 1994. A total of 1,538 patients were enrolled between JWte 1993 and May 1994. Of them, only 40 patients were found to have discontinued from BRAC treatment. Among these patients, 20 (50%) defaulted or dropped out, 5 (12.5%) were migrated and the rest 15 (37.5%) were referred to TB clinic or hospital for treatment. 2019-11-11T10:47:20Z 2019-11-11T10:47:20Z 1996-12 Research report Karim, F., Mahmud, S. N., Ali, A., & Islam, M. N. (1996, December). Reasons for discontinuation of tuberculosis treatment provided by BRAC. Research Reports (1996): Health Studies, Vol - XX, 225–246. http://hdl.handle.net/10361/12909 en application/pdf BRAC Research and Evaluation Division (RED)
institution Brac University
collection Institutional Repository
language English
topic Tuberculosis
BRAC
Women's Health and Development Programme (WHDP)
Tuberculosis--Treatment
Health, Nutrition, and Population Program (BRAC)
spellingShingle Tuberculosis
BRAC
Women's Health and Development Programme (WHDP)
Tuberculosis--Treatment
Health, Nutrition, and Population Program (BRAC)
Mahmud, Shah Noor
Ali, Ahmed
Islam, Md. Nazrul
Karim, Fazlul
Reasons for discontinuation of tuberculosis treatment provided by BRAC
description To supplement the government tuberculosic; control programme, BRAC has initiated a communitybased tuberculosis programme in 10 thanas under the Women's Health and Development Programme (WHDP) (presently known as Reproductive Health and Disease Control - RHDC) since June 1992. BRAC is delivering services and following up the patients for all compliance. But, a recent study showed that the treatment completion rate achieved was up to 85% (1). Now the question arises: why the remaining 15% of the patients did not complete their treatment course? This study aimed to assess the reasons for discontinuation of treatment from BRAC's community-based TB control programme. The study was carried out in all10 WHDP thanas and dealt with the patients receiving only 12 months treatment regimen. The patients who enrolled and later discontinued treatment dwing June 1993 to May 1994 were selected for the study. Reasons for discontinuation of treatment were collected from progranune records, the patient or his/her relatives, Shastho Shebikas (SSs), Programme Organisers (POs), Area Managers (AMs) and Medical Officers (MOs) through indepth interviews during J\Ule and August 1994. A total of 1,538 patients were enrolled between JWte 1993 and May 1994. Of them, only 40 patients were found to have discontinued from BRAC treatment. Among these patients, 20 (50%) defaulted or dropped out, 5 (12.5%) were migrated and the rest 15 (37.5%) were referred to TB clinic or hospital for treatment.
format Research report
author Mahmud, Shah Noor
Ali, Ahmed
Islam, Md. Nazrul
Karim, Fazlul
author_facet Mahmud, Shah Noor
Ali, Ahmed
Islam, Md. Nazrul
Karim, Fazlul
author_sort Mahmud, Shah Noor
title Reasons for discontinuation of tuberculosis treatment provided by BRAC
title_short Reasons for discontinuation of tuberculosis treatment provided by BRAC
title_full Reasons for discontinuation of tuberculosis treatment provided by BRAC
title_fullStr Reasons for discontinuation of tuberculosis treatment provided by BRAC
title_full_unstemmed Reasons for discontinuation of tuberculosis treatment provided by BRAC
title_sort reasons for discontinuation of tuberculosis treatment provided by brac
publisher BRAC Research and Evaluation Division (RED)
publishDate 2019
url http://hdl.handle.net/10361/12909
work_keys_str_mv AT mahmudshahnoor reasonsfordiscontinuationoftuberculosistreatmentprovidedbybrac
AT aliahmed reasonsfordiscontinuationoftuberculosistreatmentprovidedbybrac
AT islammdnazrul reasonsfordiscontinuationoftuberculosistreatmentprovidedbybrac
AT karimfazlul reasonsfordiscontinuationoftuberculosistreatmentprovidedbybrac
_version_ 1814307123902808064